Federal offices designed to track pregnancy health data, manage fertility services, and address health disparities are being shut down, threatening access to critical reproductive care for millions of women and LGBTQ+ people. The closure of these agencies means the loss of national surveillance systems that monitor pregnancy complications, assisted reproductive technology (ART) outcomes, and family planning services that serve disproportionately affected communities. Which Federal Offices Are Closing and What Do They Do? The Trump-Vance administration has eliminated or severely reduced staffing at multiple federal agencies responsible for reproductive health oversight. These closures represent a significant shift in how the nation monitors and supports pregnancy, fertility, and family planning services. - Office of Infectious Disease and HIV/AIDS Policy: This HHS office led the national strategy to end the HIV epidemic, managed the Minority HIV/AIDS Fund, and provided vital analysis for eliminating infectious conditions that complicate pregnancy and fertility outcomes. - Pregnancy Risk Assessment Monitoring System (PRAMS): CDC staff managing this critical data collection system have been significantly reduced, limiting the nation's ability to track pregnancy complications and maternal health trends across different populations. - Assisted Reproductive Technology (ART) Surveillance System: Staffing cuts to this CDC office mean reduced monitoring of IVF and other fertility treatment outcomes, making it harder to identify disparities in fertility care access and success rates. - Office of Population Affairs: This office manages Title X family planning grants that fund clinics providing contraception, reproductive health services, and preventive care for millions of women and LGBTQ+ individuals. - Offices of Minority Health: Both HHS and Centers for Medicaid and Medicare Services (CMS) eliminated or drastically cut staff from these offices, which led national efforts to improve health outcomes for racial and ethnic minority populations. Why Are These Closures Dangerous for Pregnancy and Fertility? The elimination of these offices creates a critical gap in understanding and addressing health disparities that disproportionately affect women of color and LGBTQ+ individuals seeking to conceive or carry pregnancies to term. Without data collection and analysis, health inequities will persist and potentially worsen. Black women face particularly alarming disparities in pregnancy outcomes. Pregnancy-related mortality for Black women is over three times the rate of white women, yet the closure of PRAMS and other surveillance systems means fewer resources to understand why these disparities exist or how to prevent them. Similarly, Black women are twice as likely to die from endometrial cancer and 40% more likely to die from breast cancer than white women, conditions that can be affected by pregnancy history and reproductive choices. For those pursuing fertility treatment, the reduction in ART surveillance staff means less oversight of IVF clinic outcomes and reduced ability to identify which clinics serve minority populations effectively or where disparities in treatment success exist. This lack of data makes it harder for patients to make informed decisions about fertility clinics and harder for regulators to ensure equitable access to treatment. How Are Cuts to Family Planning Services Affecting Conception and Pregnancy Planning? The drastic reduction in staff managing Title X family planning grants threatens access to contraception, STI testing, cancer screenings, and reproductive counseling services. These services are foundational to healthy pregnancy planning and conception. When access to contraception is restricted, women lose the ability to plan pregnancies according to their health status and life circumstances. This can result in unintended pregnancies, which carry greater risks of maternal depression and increased susceptibility to sexually transmitted infections (STIs). Additionally, barriers to STI testing increase transmission rates and untreated infections, which can lead to severe complications including infertility and certain cancers. For LGBTQ+ individuals seeking to conceive or access fertility services, the loss of Title X funding and staff support means fewer clinics equipped to provide culturally competent care. LGBTQ+ people already manage chronic conditions at higher rates than their non-LGBTQ+ peers and face barriers to accessing reproductive health services. What Happens When HIV Surveillance and Prevention Services Decline? The closure of the Office of Infectious Disease and HIV/AIDS Policy threatens progress toward ending the HIV epidemic, which has direct implications for pregnancy and fertility. Tens of thousands of new HIV infections occur each year, with 1.2 million people currently living with HIV in the United States. New HIV infections disproportionately impact Black women and transgender women, populations already facing significant barriers to reproductive health care. HIV infections can complicate heart disease, cancer, and diabetes risks, making new infections particularly dangerous for women of color who already experience high rates of chronic conditions. Without up-to-date HIV data collection and prevention services, it will be difficult to identify trends and ensure that women and LGBTQ+ people with HIV receive adequate treatment. A decrease in prevention and support services will likely cause a spike in infection rates, and inadequate access to HIV treatments could contribute to stronger or drug-resistant strains of HIV. Steps to Protect Your Reproductive Health During This Period of Uncertainty - Seek care at established Title X clinics: Before these services are further reduced, connect with federally qualified health centers and Title X-funded clinics in your area that provide contraception, STI testing, and reproductive counseling. These clinics serve low-income and underinsured patients and offer sliding-scale fees. - Get comprehensive STI and HIV testing: If you are planning to conceive or are sexually active, obtain current STI and HIV testing through your healthcare provider or local health department. Early detection and treatment prevent complications that can affect fertility and pregnancy outcomes. - Document your health data: Keep detailed records of your reproductive health, including menstrual cycles, contraceptive use, pregnancy history, and any fertility concerns. This information becomes more valuable as centralized data collection systems are reduced. - Advocate for continued funding: Contact your elected representatives to express support for maintaining federal offices that track pregnancy outcomes, manage fertility services, and address health disparities in reproductive care. What Does This Mean for Women of Color and LGBTQ+ Individuals? The cumulative effect of these office closures is a significant reduction in the nation's ability to identify, track, and address health disparities in pregnancy and fertility care. Women of color, disabled women, and LGBTQ+ individuals rely disproportionately on Medicaid and Title X services, making them especially vulnerable to these cuts. Without the Offices of Minority Health, there will be fewer national grants and programs, less data collection and analysis, and fewer awareness campaigns designed to improve health outcomes for underserved communities. This means that the persistent disparities in pregnancy-related mortality, fertility treatment access, and reproductive health outcomes will likely continue to worsen without intervention or oversight. The closure of these federal offices represents a significant setback for reproductive health equity. Women and LGBTQ+ individuals who have historically been marginalized by the healthcare system will face even greater barriers to accessing fertility services, contraception, STI testing, and pregnancy care. Advocacy for the restoration of these offices and the data systems they manage is critical to ensuring that all individuals have equitable access to reproductive health services and information.
